Home » Topics » Regulatory

Regulatory
RSS

Bexxar approved by FDA

July 2, 2003

Enbrel recommended by FDA panel to treat ankylosing spondylitis

June 30, 2003

Gemzar/Taxol approved in Finland for metastatic breast cancer

June 27, 2003

FDA approval of Striant for testosterone replacement therapy

June 25, 2003

FDA approves Reyataz for HIV-1 infection

June 25, 2003

Arixtra approved for extended use

June 23, 2003

Arava cleared for improving physical function in rheumatoid arthritis patients

June 20, 2003

FDA approves FluMist as first intranasal influenza vaccine

June 19, 2003

Metvix label extension recommended in Australia

June 19, 2003

Extended-release alfuzosin approved for BPH

June 18, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...